Which has preferable valuation & earnings, TEM or ADUS?

Addus HomeCare has higher revenue and earnings than Tempus AI. Tempus AI is trading at a lower price-to-earnings ratio than Addus HomeCare, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Tempus AI $1.27B 7.81 -$245.03M -$1.44 N/A Addus HomeCare $1.42B 1.57 $95.91M $5.70 20.94

Is TEM or ADUS more profitable?

Addus HomeCare has a net margin of 7.13% compared to Tempus AI's net margin of -17.77%. Addus HomeCare's return on equity of 9.96% beat Tempus AI's return on equity. Company Net Margins Return on Equity Return on Assets Tempus AI -17.77% -50.28% -10.33% Addus HomeCare 7.13% 9.96% 7.62%

Does the media prefer TEM or ADUS?

In the previous week, Tempus AI had 2 more articles in the media than Addus HomeCare. MarketBeat recorded 13 mentions for Tempus AI and 11 mentions for Addus HomeCare. Addus HomeCare's average media sentiment score of 0.68 beat Tempus AI's score of -0.25 indicating that Addus HomeCare is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tempus AI 4 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral Addus HomeCare 4 Very Positive mention(s) 0 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to HIMS or ADUS?

In the previous week, Hims & Hers Health had 15 more articles in the media than Addus HomeCare. MarketBeat recorded 26 mentions for Hims & Hers Health and 11 mentions for Addus HomeCare. Addus HomeCare's average media sentiment score of 0.68 beat Hims & Hers Health's score of 0.39 indicating that Addus HomeCare is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hims & Hers Health 6 Very Positive mention(s) 1 Positive mention(s) 13 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral Addus HomeCare 4 Very Positive mention(s) 0 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings & valuation, ADUS or CHE?

Chemed has higher revenue and earnings than Addus HomeCare. Addus HomeCare is trading at a lower price-to-earnings ratio than Chemed, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Addus HomeCare $1.42B 1.57 $95.91M $5.70 20.94 Chemed $2.53B 2.84 $265.24M $19.91 27.60

Is ADUS or CHE more profitable?

Chemed has a net margin of 10.60% compared to Addus HomeCare's net margin of 7.13%. Chemed's return on equity of 31.77% beat Addus HomeCare's return on equity. Company Net Margins Return on Equity Return on Assets Addus HomeCare 7.13% 9.96% 7.62% Chemed 10.60% 31.77% 18.90%

Does the media favor ADUS or CHE?

In the previous week, Chemed had 1 more articles in the media than Addus HomeCare. MarketBeat recorded 12 mentions for Chemed and 11 mentions for Addus HomeCare. Chemed's average media sentiment score of 0.73 beat Addus HomeCare's score of 0.68 indicating that Chemed is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Addus HomeCare 4 Very Positive mention(s) 0 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Chemed 7 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher valuation and earnings, ADUS or BLLN?

Addus HomeCare has higher revenue and earnings than Billiontoone. Addus HomeCare is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Addus HomeCare $1.42B 1.57 $95.91M $5.70 20.94 Billiontoone $305.11M 14.87 $7.45M $0.70 140.93

Is ADUS or BLLN more profitable?

Billiontoone has a net margin of 8.04% compared to Addus HomeCare's net margin of 7.13%. Company Net Margins Return on Equity Return on Assets Addus HomeCare 7.13% 9.96% 7.62% Billiontoone 8.04% 9.96% 5.35%

Does the media prefer ADUS or BLLN?

In the previous week, Billiontoone had 18 more articles in the media than Addus HomeCare. MarketBeat recorded 29 mentions for Billiontoone and 11 mentions for Addus HomeCare. Addus HomeCare's average media sentiment score of 0.68 beat Billiontoone's score of 0.21 indicating that Addus HomeCare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Addus HomeCare 4 Very Positive mention(s) 0 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Billiontoone 8 Very Positive mention(s) 3 Positive mention(s) 6 Neutral mention(s) 5 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has stronger valuation & earnings, ADUS or HNGE?

Addus HomeCare has higher revenue and earnings than Hinge Health. Addus HomeCare is trading at a lower price-to-earnings ratio than Hinge Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Addus HomeCare $1.42B 1.57 $95.91M $5.70 20.94 Hinge Health $587.86M 12.02 -$528.26M $1.28 71.35

Does the media favor ADUS or HNGE?

In the previous week, Hinge Health had 15 more articles in the media than Addus HomeCare. MarketBeat recorded 26 mentions for Hinge Health and 11 mentions for Addus HomeCare. Addus HomeCare's average media sentiment score of 0.68 beat Hinge Health's score of 0.61 indicating that Addus HomeCare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Addus HomeCare 4 Very Positive mention(s) 0 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Hinge Health 5 Very Positive mention(s) 4 Positive mention(s) 10 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive

Addus HomeCare (ADUS) Competitors

$119.34 -0.34 (-0.28%)

As of 04:00 PM Eastern

Compare

ADUS vs. TEM, HIMS, CHE, BLLN, and HNGE

Should you buy Addus HomeCare stock or one of its competitors? MarketBeat compares Addus HomeCare with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Addus HomeCare include Tempus AI (TEM), Hims & Hers Health (HIMS), Chemed (CHE), Billiontoone (BLLN), and Hinge Health (HNGE). These companies are all part of the "healthcare services" industry.

How does Addus HomeCare compare to Tempus AI?

Tempus AI (NASDAQ:TEM) and Addus HomeCare (NASDAQ:ADUS) are both mid-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, media sentiment, valuation, dividends, profitability, risk and analyst recommendations.

In the previous week, Tempus AI had 2 more articles in the media than Addus HomeCare. MarketBeat recorded 13 mentions for Tempus AI and 11 mentions for Addus HomeCare. Addus HomeCare's average media sentiment score of 0.68 beat Tempus AI's score of -0.25 indicating that Addus HomeCare is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Tempus AI	4 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Neutral
Addus HomeCare	4 Very Positive mention(s)	0 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Addus HomeCare has a net margin of 7.13% compared to Tempus AI's net margin of -17.77%. Addus HomeCare's return on equity of 9.96% beat Tempus AI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tempus AI	-17.77%	-50.28%	-10.33%
Addus HomeCare	7.13%	9.96%	7.62%

Addus HomeCare has higher revenue and earnings than Tempus AI. Tempus AI is trading at a lower price-to-earnings ratio than Addus HomeCare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tempus AI	$1.27B	7.81	-$245.03M	-$1.44	N/A
Addus HomeCare	$1.42B	1.57	$95.91M	$5.70	20.94

24.2% of Tempus AI shares are owned by institutional investors. Comparatively, 95.4% of Addus HomeCare shares are owned by institutional investors. 24.3% of Tempus AI shares are owned by company insiders. Comparatively, 4.1% of Addus HomeCare shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Tempus AI presently has a consensus target price of $64.92, indicating a potential upside of 17.91%. Addus HomeCare has a consensus target price of $130.88, indicating a potential upside of 9.67%. Given Tempus AI's higher possible upside, analysts clearly believe Tempus AI is more favorable than Addus HomeCare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tempus AI	2 Sell rating(s)	6 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.41
Addus HomeCare	1 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.73

Tempus AI has a beta of 3.58, suggesting that its stock price is 258% more volatile than the broader market. Comparatively, Addus HomeCare has a beta of 0.87, suggesting that its stock price is 13% less volatile than the broader market.

Summary

Addus HomeCare beats Tempus AI on 11 of the 17 factors compared between the two stocks.

How does Addus HomeCare compare to Hims & Hers Health?

Hims & Hers Health (NYSE:HIMS) and Addus HomeCare (NASDAQ:ADUS) are both mid-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, profitability, institutional ownership, analyst recommendations, valuation, dividends, media sentiment and risk.

Hims & Hers Health currently has a consensus target price of $31.43, indicating a potential downside of 1.18%. Addus HomeCare has a consensus target price of $130.88, indicating a potential upside of 9.67%. Given Addus HomeCare's stronger consensus rating and higher probable upside, analysts clearly believe Addus HomeCare is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	1 Sell rating(s)	11 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.19
Addus HomeCare	1 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.73

Addus HomeCare has a net margin of 7.13% compared to Hims & Hers Health's net margin of -0.56%. Addus HomeCare's return on equity of 9.96% beat Hims & Hers Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	-0.56%	6.10%	1.52%
Addus HomeCare	7.13%	9.96%	7.62%

Hims & Hers Health has higher revenue and earnings than Addus HomeCare. Hims & Hers Health is trading at a lower price-to-earnings ratio than Addus HomeCare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hims & Hers Health	$2.35B	3.14	$128.37M	-$0.09	N/A
Addus HomeCare	$1.42B	1.57	$95.91M	$5.70	20.94

In the previous week, Hims & Hers Health had 15 more articles in the media than Addus HomeCare. MarketBeat recorded 26 mentions for Hims & Hers Health and 11 mentions for Addus HomeCare. Addus HomeCare's average media sentiment score of 0.68 beat Hims & Hers Health's score of 0.39 indicating that Addus HomeCare is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hims & Hers Health	6 Very Positive mention(s)	1 Positive mention(s)	13 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Neutral
Addus HomeCare	4 Very Positive mention(s)	0 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Hims & Hers Health has a beta of 2.4, indicating that its stock price is 140% more volatile than the broader market. Comparatively, Addus HomeCare has a beta of 0.87, indicating that its stock price is 13% less volatile than the broader market.

63.5% of Hims & Hers Health shares are owned by institutional investors. Comparatively, 95.4% of Addus HomeCare shares are owned by institutional investors. 11.8% of Hims & Hers Health shares are owned by insiders. Comparatively, 4.1% of Addus HomeCare shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Addus HomeCare beats Hims & Hers Health on 11 of the 17 factors compared between the two stocks.

How does Addus HomeCare compare to Chemed?

Addus HomeCare (NASDAQ:ADUS) and Chemed (NYSE:CHE) are both mid-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, analyst recommendations, institutional ownership, valuation, dividends and profitability.

95.4% of Addus HomeCare shares are held by institutional investors. Comparatively, 95.9% of Chemed shares are held by institutional investors. 4.1% of Addus HomeCare shares are held by insiders. Comparatively, 3.3% of Chemed shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Chemed had 1 more articles in the media than Addus HomeCare. MarketBeat recorded 12 mentions for Chemed and 11 mentions for Addus HomeCare. Chemed's average media sentiment score of 0.73 beat Addus HomeCare's score of 0.68 indicating that Chemed is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Addus HomeCare	4 Very Positive mention(s)	0 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Chemed	7 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Chemed has higher revenue and earnings than Addus HomeCare. Addus HomeCare is trading at a lower price-to-earnings ratio than Chemed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Addus HomeCare	$1.42B	1.57	$95.91M	$5.70	20.94
Chemed	$2.53B	2.84	$265.24M	$19.91	27.60

Addus HomeCare presently has a consensus target price of $130.88, suggesting a potential upside of 9.67%. Chemed has a consensus target price of $530.75, suggesting a potential downside of 3.42%. Given Addus HomeCare's stronger consensus rating and higher possible upside, analysts clearly believe Addus HomeCare is more favorable than Chemed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Addus HomeCare	1 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.73
Chemed	0 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.17

Addus HomeCare has a beta of 0.87, meaning that its stock price is 13% less volatile than the broader market. Comparatively, Chemed has a beta of 0.51, meaning that its stock price is 49% less volatile than the broader market.

Chemed has a net margin of 10.60% compared to Addus HomeCare's net margin of 7.13%. Chemed's return on equity of 31.77% beat Addus HomeCare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Addus HomeCare	7.13%	9.96%	7.62%
Chemed	10.60%	31.77%	18.90%

Summary

Chemed beats Addus HomeCare on 11 of the 17 factors compared between the two stocks.

How does Addus HomeCare compare to Billiontoone?

Addus HomeCare (NASDAQ:ADUS) and Billiontoone (NASDAQ:BLLN) are both mid-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, media sentiment, risk, profitability, earnings, valuation and dividends.

Billiontoone has a net margin of 8.04% compared to Addus HomeCare's net margin of 7.13%.

Company	Net Margins	Return on Equity	Return on Assets
Addus HomeCare	7.13%	9.96%	7.62%
Billiontoone	8.04%	9.96%	5.35%

Addus HomeCare currently has a consensus price target of $130.88, indicating a potential upside of 9.67%. Billiontoone has a consensus price target of $126.71, indicating a potential upside of 28.45%. Given Billiontoone's higher probable upside, analysts plainly believe Billiontoone is more favorable than Addus HomeCare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Addus HomeCare	1 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.73
Billiontoone	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50

In the previous week, Billiontoone had 18 more articles in the media than Addus HomeCare. MarketBeat recorded 29 mentions for Billiontoone and 11 mentions for Addus HomeCare. Addus HomeCare's average media sentiment score of 0.68 beat Billiontoone's score of 0.21 indicating that Addus HomeCare is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Addus HomeCare	4 Very Positive mention(s)	0 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Billiontoone	8 Very Positive mention(s)	3 Positive mention(s)	6 Neutral mention(s)	5 Negative mention(s)	0 Very Negative mention(s)	Neutral

Addus HomeCare has higher revenue and earnings than Billiontoone. Addus HomeCare is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Addus HomeCare	$1.42B	1.57	$95.91M	$5.70	20.94
Billiontoone	$305.11M	14.87	$7.45M	$0.70	140.93

95.4% of Addus HomeCare shares are owned by institutional investors. 4.1% of Addus HomeCare shares are owned by company insiders. Comparatively, 50.2% of Billiontoone shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Addus HomeCare beats Billiontoone on 9 of the 15 factors compared between the two stocks.

How does Addus HomeCare compare to Hinge Health?

Addus HomeCare (NASDAQ:ADUS) and Hinge Health (NYSE:HNGE) are both mid-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, earnings, valuation, profitability, dividends, institutional ownership, analyst recommendations and media sentiment.

Addus HomeCare has a beta of 0.87, suggesting that its stock price is 13% less volatile than the broader market. Comparatively, Hinge Health has a beta of 1.31, suggesting that its stock price is 31% more volatile than the broader market.

Addus HomeCare presently has a consensus target price of $130.88, suggesting a potential upside of 9.67%. Hinge Health has a consensus target price of $100.57, suggesting a potential upside of 10.12%. Given Hinge Health's stronger consensus rating and higher probable upside, analysts plainly believe Hinge Health is more favorable than Addus HomeCare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Addus HomeCare	1 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.73
Hinge Health	1 Sell rating(s)	1 Hold rating(s)	14 Buy rating(s)	2 Strong Buy rating(s)	2.94

Hinge Health has a net margin of 15.15% compared to Addus HomeCare's net margin of 7.13%. Hinge Health's return on equity of 65.44% beat Addus HomeCare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Addus HomeCare	7.13%	9.96%	7.62%
Hinge Health	15.15%	65.44%	14.54%

95.4% of Addus HomeCare shares are owned by institutional investors. 4.1% of Addus HomeCare shares are owned by company insiders. Comparatively, 18.9% of Hinge Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Hinge Health had 15 more articles in the media than Addus HomeCare. MarketBeat recorded 26 mentions for Hinge Health and 11 mentions for Addus HomeCare. Addus HomeCare's average media sentiment score of 0.68 beat Hinge Health's score of 0.61 indicating that Addus HomeCare is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Addus HomeCare	4 Very Positive mention(s)	0 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Hinge Health	5 Very Positive mention(s)	4 Positive mention(s)	10 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Addus HomeCare has higher revenue and earnings than Hinge Health. Addus HomeCare is trading at a lower price-to-earnings ratio than Hinge Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Addus HomeCare	$1.42B	1.57	$95.91M	$5.70	20.94
Hinge Health	$587.86M	12.02	-$528.26M	$1.28	71.35

Summary

Hinge Health beats Addus HomeCare on 12 of the 17 factors compared between the two stocks.

Get Addus HomeCare News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ADUS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ADUS vs. The Competition

Export

Metric	Addus HomeCare	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$2.23B	$9.98B	$7.05B	$12.94B
Dividend Yield	N/A	2.55%	2.58%	10.20%
P/E Ratio	20.94	25.71	269.76	24.76
Price / Sales	1.57	4.85	651.81	108.50
Price / Cash	18.43	25.58	28.89	37.44
Price / Book	2.03	5.37	11.28	6.42
Net Income	$95.91M	$309.96M	$3.45B	$347.27M
7 Day Performance	2.18%	0.97%	3.61%	2.52%
1 Month Performance	10.29%	0.42%	-0.53%	-1.00%
1 Year Performance	8.30%	23.39%	77.55%	23.29%

Addus HomeCare Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ADUS Addus HomeCare	3.1221 of 5 stars	$119.34 -0.3%	$130.88 +9.7%	+8.6%	$2.23B	$1.42B	20.94	50,659	Earnings Report
TEM Tempus AI	2.9468 of 5 stars	$46.67 +1.4%	$64.92 +39.1%	-14.5%	$8.40B	$1.27B	N/A	3,800
HIMS Hims & Hers Health	2.0781 of 5 stars	$31.45 +2.0%	$31.43 0.0%	-39.1%	$7.28B	$2.35B	N/A	2,442
CHE Chemed	3.805 of 5 stars	$535.65 -0.9%	$530.75 -0.9%	+26.7%	$7.11B	$2.53B	26.90	15,811	Dividend Increase
BLLN Billiontoone	4.4052 of 5 stars	$138.49 +0.9%	$126.00 -9.0%	N/A	$6.37B	$305.11M	252.01	620	Earnings Report Analyst Downgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ADUS) was last updated on 8/10/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Addus HomeCare (ADUS) Competitors

ADUS vs. TEM, HIMS, CHE, BLLN, and HNGE

How does Addus HomeCare compare to Tempus AI?

Summary

How does Addus HomeCare compare to Hims & Hers Health?

Summary

How does Addus HomeCare compare to Chemed?

Summary

How does Addus HomeCare compare to Billiontoone?

Summary

How does Addus HomeCare compare to Hinge Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ADUS vs. The Competition

Addus HomeCare Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Addus HomeCare (ADUS) Competitors

ADUS vs. TEM, HIMS, CHE, BLLN, and HNGE

How does Addus HomeCare compare to Tempus AI?

Does the media prefer TEM or ADUS?

Is TEM or ADUS more profitable?

Which has preferable valuation & earnings, TEM or ADUS?

Do institutionals and insiders have more ownership in TEM or ADUS?

Do analysts recommend TEM or ADUS?

Which has more volatility and risk, TEM or ADUS?

Summary

How does Addus HomeCare compare to Hims & Hers Health?

Do analysts prefer HIMS or ADUS?

Is HIMS or ADUS more profitable?

Which has stronger valuation and earnings, HIMS or ADUS?

Does the media refer more to HIMS or ADUS?

Which has more risk and volatility, HIMS or ADUS?

Do insiders & institutionals believe in HIMS or ADUS?

Summary

How does Addus HomeCare compare to Chemed?

Do insiders & institutionals believe in ADUS or CHE?

Does the media favor ADUS or CHE?

Which has better earnings & valuation, ADUS or CHE?

Do analysts prefer ADUS or CHE?

Which has more volatility & risk, ADUS or CHE?

Is ADUS or CHE more profitable?

Summary

How does Addus HomeCare compare to Billiontoone?

Is ADUS or BLLN more profitable?

Do analysts recommend ADUS or BLLN?

Does the media prefer ADUS or BLLN?

Which has higher valuation and earnings, ADUS or BLLN?

Do insiders & institutionals have more ownership in ADUS or BLLN?

Summary

How does Addus HomeCare compare to Hinge Health?

Which has more risk & volatility, ADUS or HNGE?

Do analysts rate ADUS or HNGE?

Is ADUS or HNGE more profitable?

Do insiders & institutionals hold more shares of ADUS or HNGE?

Does the media favor ADUS or HNGE?

Which has stronger valuation & earnings, ADUS or HNGE?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ADUS vs. The Competition

Addus HomeCare Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools